Inscrição YC de Exin Therapeutics

Winter 2025Active

Exin Therapeutics passou pela Y Combinator no batch Winter 2025 como uma empresa Healthcare. Abaixo: o que a empresa faz, quem a fundou e sua inscrição para a YC, reconstruída pergunta por pergunta no formulário real da YC.

Batch YC: Winter 2025
Indústria: HealthcareTherapeutics
Tamanho da equipe: 9
Status: Active
Lançada: 2025

Fundadores

Gabriel Ocana SanteroFounder
Marko TvrdicFounder

O que Exin Therapeutics faz

We use AI and high-throughput mouse studies to discover therapeutics that modify neural activity in the brain. The initial focus is on epilepsies associated with autism and Parkinson’s disease with the potential to expand to any neurological disorder underlined by a dysfunction in neural activity. Our R&D is guided by AI models trained on high-density multimodal mouse data generated in-house. We are 3 Oxford-trained neuroscientists supported by an experienced SAB from Harvard, Science Corp (ex-Neuralink), EPFL, Meta, and UCL. In 1.5 months since landing in SF, we went from nothing to (1) opening and operating an animal lab in South SF, (2) obtaining a proof-of-concept in mice, (3) building a multimodal AI model that directs our screening approach and (4) submitting two provisional patents; all while utilizing less than 50% of our YC funding.

Inscrição YC de Exin Therapeutics, reconstruída

Inscrição Y Combinator

Exin Therapeutics, lote Winter 2025. As verdadeiras perguntas do formulário, respondidas com dados públicos.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Exin Therapeutics

Describe what your company does in 50 characters or less.

AI drug discovery platform for neurotherapeutics

What is your company going to make? Please describe your product and what it does or will do.

We are building an AI-driven platform that analyzes high-density multimodal mouse data to discover drugs that modify neural activity. Initially, we target epilepsies associated with autism and Parkinson's disease, but our approach could extend to other neurological disorders involving dysfunctional neural activity.

Where do you live now, and where would the company be based after YC?

We live in San Francisco, CA, and the company is based here post-YC.

Explain your decision regarding location.

We are in San Francisco to be close to biotech investors, collaborators, and research talent. Setting up an animal lab here allows fast iteration between AI insights and in vivo validation, which is key for our approach.

21 respostas a mais na inscrição completa

Founders, Progress, Idea, Equity, Curious, Batch Preference estão na versão completa. Crie uma conta gratuita para abri-la no YC Insights, ao lado de todos os outros batches da YC.

Ver inscrição completa

Perguntas Frequentes

Esta é a inscrição real da YC de Exin Therapeutics?

Não. A Y Combinator mantém as inscrições submetidas em privado. Esta é uma reconstrução: as perguntas reais do formulário da YC, respondidas a partir dos dados públicos de Exin Therapeutics (notas de lançamento, históricos de fundadores, descrição do produto). Mostra como uma empresa como Exin Therapeutics se apresentaria à YC, não o texto que eles submeteram.

Em qual batch da YC Exin Therapeutics esteve?

Exin Therapeutics fez parte do batch Winter 2025 da Y Combinator.

Quem fundou o Exin Therapeutics?

O Exin Therapeutics foi fundado por Gabriel Ocana Santero, Marko Tvrdic.

O que o Exin Therapeutics faz?

AI drug discovery platform for neurotherapeutics

Como eu leio o application completo reconstruído?

Crie uma conta gratuita no Round Funded. A versão completa de 26 respostas do application do Exin Therapeutics, e de todos os outros lotes do YC, está no YC Insights.